Korean J Intern Med.  2014 Jul;29(4):466-473.

Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease

Affiliations
  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine, Seoul, Korea. jinhwalee@ewha.ac.kr
  • 2Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.

Abstract

BACKGROUND/AIMS
Gastroesophageal reflux disease is one of the most common causes of chronic cough and is a potential risk factor for the exacerbation of chronic obstructive pulmonary disease (COPD). The aim of this study was to investigate the prevalence and risk factors for reflux esophagitis (RE) in COPD patients.
METHODS
From our hospital database, between September 2006 and April 2010, we searched for subjects who were 40 years old or older and had undergone both postbronchodilator spirometry and esophagogastroduodenoscopy (EGD). COPD was defined as having a ratio of forced expiratory volume in 1 second to forced vital capacity < 0.7 in postbronchodilator spirometry and no abnormality causing airway obstruction, except emphysematous changes, on a chest X-ray. The diagnosis of RE was based on a mucosal break surrounding the distal esophageal sphincter through EGD.
RESULTS
In total, 253 patients with COPD were enrolled. The prevalence of RE in COPD was 30% (76/253). Multiple logistic regression analyses revealed that age (odds ratio [OR], 0.950; 95% confidence interval [CI], 0.918 to 0.983; p = 0.003), smoking pack-years (OR, 1.015; 95% CI, 1.004 to 1.025; p = 0.006), and inhaled anticholinergics (OR, 0.516; 95% CI, 0.271 to 0.982; p = 0.044) were independently associated with RE in COPD patients.
CONCLUSIONS
The prevalence of RE in our COPD patients was higher than that reported previously in the Korean general population. In COPD, smoking increased the risk of RE, whereas inhaled anticholinergics may be associated with a reduced risk of RE.

Keyword

Pulmonary disease, chronic obstructive; Esophagitis, peptic; Prevalence; Risk factors

MeSH Terms

Administration, Inhalation
Aged
Chi-Square Distribution
Cholinergic Antagonists/administration & dosage
Comorbidity
Databases, Factual
Endoscopy, Gastrointestinal
Esophagitis, Peptic/diagnosis/*epidemiology
Female
Humans
Logistic Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Prevalence
Protective Factors
Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy/*epidemiology
Republic of Korea/epidemiology
Retrospective Studies
Risk Factors
Smoking/adverse effects/epidemiology
Spirometry
Cholinergic Antagonists
Full Text Links
  • KJIM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr